Showing results (1711-1720 of 1,908) with videos related to

Sort By:
Pageof 191
The Journal of Pathology|January 17, 2012
Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transitionSan-Cher Chen, Mei-Lang Kung, Tsung-Hui Hu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained respondersFai-Meng Sou, Cheng-Kun Wu, Kuo-Chin Chang, et al.
International Journal of Cancer|February 17, 2007
Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern TaiwanKwong-Ming Kee, Jing-Houng Wang, Chuan-Mo Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2007
P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resectionJung-Ta Kao, Seng-Kee Chuah, Chao-Cheng Huang, et al.
Plos One|August 21, 2014
The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradicationWei-Chen Tai, Chen-Hsiang Lee, Shue-Shian Chiou, et al.
Journal of Hepatocellular Carcinoma|December 8, 2025
Intensity-Modulated Proton Therapy for Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisChieh-Min Liu, Chia-Hsuan Lai, Yu-Ming Wang, et al.
Biochemical and Biophysical Research Communications|July 24, 2012
Hepatoma-derived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3-kinase/Akt pathwayMei-Lang Kung, Han-En Tsai, Tsung-Hui Hu, et al.
The Journal of Antimicrobial Chemotherapy|August 18, 2012
A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapyKuo-Chin Chang, Chao-Hung Hung, Sheng-Nan Lu, et al.
Surgical Oncology|April 25, 2022
Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East AsiaYueh-Wei Liu, Yi-Hao Yen, Wei-Feng Li, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 13, 2025
Hepatoma-Derived Growth Factor Promotes Liver Carcinogenesis by Inducing Phosphatase and Tensin Homolog InactivationShih-Ming Yang, Tsung-Hui Hu, Jian-Ching Wu, et al.
Pageof 191